Abstract
Recent advances in our understanding of the molecular basis of neoplasia and of the mechanics underlying activation of the immune system provide us with exciting new possibilities for the treatment of cancer. This article reviews several of the recent developments that may enter widespread clinical use by the start of the next century. Indeed, the twenty-first century may well become for medicine, the era of gene therapy and molecular pharmacology.
Get full access to this article
View all access options for this article.
